Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial

BACKGROUND: Treatment of dysplastic Barrett's oesophagus prevents progression to adenocarcinoma; however, the optimal diagnostic strategy for Barrett's oesophagus is unclear. The Cytosponge-trefoil factor 3 (TFF3) is a non-endoscopic test for Barrett's oesophagus. The aim of this stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Fitzgerald, Rebecca C, di Pietro, Massimiliano, O'Donovan, Maria, Maroni, Roberta, Muldrew, Beth, Debiram-Beecham, Irene, Gehrung, Marcel, Offman, Judith, Tripathi, Monika, Smith, Samuel G, Aigret, Benoit, Walter, Fiona M, Rubin, Greg, Sasieni, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408501/
https://www.ncbi.nlm.nih.gov/pubmed/32738955
http://dx.doi.org/10.1016/S0140-6736(20)31099-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408501/
https://www.ncbi.nlm.nih.gov/pubmed/32738955
http://dx.doi.org/10.1016/S0140-6736(20)31099-0

Ejemplares similares